Necrotizing enterocolitis of the newborn: pathogenetic concepts in perspective

Pediatr Dev Pathol. Jan-Feb 1998;1(1):2-16. doi: 10.1007/s100249900002.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Animals, Newborn
  • Azepines / pharmacology
  • Disease Models, Animal
  • Drug Synergism
  • Enterocolitis, Necrotizing / chemically induced
  • Enterocolitis, Necrotizing / etiology*
  • Enterocolitis, Necrotizing / pathology
  • Food, Formulated / adverse effects
  • Humans
  • Hypoxia
  • Infant, Newborn
  • Intestines / drug effects
  • Intestines / microbiology
  • Intestines / pathology
  • Lipopolysaccharides / adverse effects
  • Mice
  • NF-kappa B / metabolism
  • Necrosis
  • Platelet Activating Factor / adverse effects
  • Platelet Activating Factor / antagonists & inhibitors
  • Platelet Activating Factor / physiology
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Membrane Glycoproteins / antagonists & inhibitors
  • Rats
  • Receptors, Cell Surface*
  • Receptors, G-Protein-Coupled*
  • Triazoles / pharmacology
  • Tumor Necrosis Factor-alpha / adverse effects
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Azepines
  • Lipopolysaccharides
  • NF-kappa B
  • Platelet Activating Factor
  • Platelet Aggregation Inhibitors
  • Platelet Membrane Glycoproteins
  • Receptors, Cell Surface
  • Receptors, G-Protein-Coupled
  • Triazoles
  • Tumor Necrosis Factor-alpha
  • platelet activating factor receptor
  • WEB 2086
  • bepafant